Palvella Therapeutics (PVLA) Return On Equity

Annual ROE

-25.09%
-54.47%-185.40%

December 1, 2023


Summary


Performance

PVLA ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherPVLAprofitabilitymetrics:

Quarterly ROE

3.30%
NaN%

March 1, 2024


Summary


Performance

PVLA Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherPVLAprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

PVLA ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-185.4%-
3 y3 years-185.4%-
5 y5 years-185.4%-

PVLA ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-185.4%at lowat highat low
5 y5-year-185.4%at lowat highat low
alltimeall time-185.4%at lowat highat low

Palvella Therapeutics ROE History

DateAnnualQuarterly
Mar 2024
-
3.30%
DateAnnualQuarterly
Dec 2023
-25.09%(-185.4%)
-
Dec 2022
29.38%
-

FAQ

  • What is Palvella Therapeutics annual return on equity?
  • What is the all time high annual ROE for Palvella Therapeutics?
  • What is Palvella Therapeutics annual ROE year-on-year change?
  • What is Palvella Therapeutics quarterly return on equity?
  • What is the all time high quarterly ROE for Palvella Therapeutics?

What is Palvella Therapeutics annual return on equity?

The current annual ROE of PVLA is -25.09%

What is the all time high annual ROE for Palvella Therapeutics?

Palvella Therapeutics all-time high annual return on equity is 29.38%

What is Palvella Therapeutics annual ROE year-on-year change?

Over the past year, PVLA annual return on equity has changed by -54.47% (-185.40%)

What is Palvella Therapeutics quarterly return on equity?

The current quarterly ROE of PVLA is 3.30%

What is the all time high quarterly ROE for Palvella Therapeutics?

Palvella Therapeutics all-time high quarterly return on equity is 3.30%